Irsenontrine (Synonyms: E2027) |
Katalog-Nr.GC65911 |
Irsenontrin (E2027) ist ein oral aktiver und selektiver Phosphodiesterase 9 (PDE9)-Hemmer. Irsenontrin kann zur Erforschung neurologischer Erkrankungen eingesetzt werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1429509-82-9
Sample solution is provided at 25 µL, 10mM.
Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE9) inhibitor. Irsenontrine can be used for the research of neurological diseases[1][2][3].
Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 (PDE 9) inhibitor[3].
Irsenontrine (0.3, 3.3 mg/kg; p.o.) exhibits a significant ameliorative effect on the percentage of exploration of the novel object at 3.3 mg/kg in Scopolamine-induced rats[1].
Irsenontrine (1 mg/kg; p.o.) and memantine hydrochloride (1 mg/kg; p.o.) combined treatment group exhibits a significantly higher percentage of exploration of the novel object than memantine hydrochloride (1 mg/kg) alone[1].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *